Immunology and Microbiology
Allotransplantation
100%
Regulatory T Cell
62%
Kidney Transplantation
62%
Transplant Procedure
44%
Alloimmunity
41%
Genetic Variability
31%
Human T Regulatory Cell
31%
Interleukin 6
31%
DNA Polymorphism
29%
Mouse
27%
Drug Megadose
23%
T Cell Receptor
22%
T Cell
22%
Allele
22%
Kidney Graft Rejection
19%
Granzyme
18%
Mammalian Target of Rapamycin Complex 1
15%
Exosome
15%
Cytokine Production
15%
Granzyme B
15%
CD4
15%
Genetic Risk
15%
T Helper Cell
15%
Heavy Chain
15%
Myeloid-Derived Suppressor Cell
15%
Tumor Necrosis Factor
15%
Interleukin-6 Receptor
15%
Inflammasome
15%
Tumor Necrosis Factor Alpha
15%
Myeloid
15%
Chimeric Antigen Receptor
15%
Macrophage
15%
Reperfusion
15%
Proteasome
15%
Antigen-Presenting Cell
15%
CD8
15%
Cytotoxic T-Cell
15%
Interleukin 10
15%
Interleukin 2
15%
Hematopoietic Stem Cell Transplantation
15%
Rituximab
15%
Cytokine
15%
Long Term Survival
13%
Single Nucleotide Polymorphism
12%
Interleukin-6
12%
Immunotherapy
12%
Immunocompetent Cell
11%
Transforming Growth Factor Beta1
11%
Major Histocompatibility Complex
11%
Kidney Allograft Rejection
11%
Medicine and Dentistry
Graft Survival
48%
Graft Failure
37%
Kidney Allograft
36%
Kidney Graft Rejection
31%
Exosome
31%
Kidney Transplantation
27%
DNA Polymorphism
26%
Kidney Graft
24%
Allograft
19%
Urinary System
19%
Long Term Survival
17%
Transplantation
17%
Interleukin 6
15%
Interleukin 10
15%
Chimeric Antigen Receptor
15%
Myeloid-Derived Suppressor Cell
15%
Myeloid Cell
15%
Cell Therapy
15%
Immunotherapy
15%
Tumor Necrosis Factor
15%
Heavy Meromyosin
15%
Genetic Variability
15%
Heart Graft
15%
Genetic Risk
15%
Pancreas Adenocarcinoma
15%
High Endothelial Venules
15%
Wolman Disease
15%
Immunosuppressant
13%
T Cell
11%
Biopsy
10%
Organ Transplantation
10%
Neoplasm
10%
Antigen Specificity
10%
Cytokine
9%
Quality of Life
7%
Immune System
7%
Survival Rate
7%
Immune Response
7%
Anti-Inflammatory Drug
7%
Immunoregulation
7%
Doctor of Philosophy
7%
Biopsy Sample
7%
Arm
7%
Lymphocyte
7%
Clinical Study
7%
Kidney Allograft Rejection
7%
Tissue Transplantation
7%
Nanoparticle
7%
Paclitaxel
7%
Immunocompetent Cell
7%
Keyphrases
High Dose
18%
Podoplanin
15%
Urinary Exosomes
15%
Ischemia-reperfusion Injury
15%
Cardiac Graft
15%
Tumor Immunity
15%
Qa-1
15%
Kidney
15%
Nanoparticles
15%
Anti-PD-1
15%
Antigen-presenting Cells
15%
Treg
15%
Granzyme B
15%
Human Regulatory T Cells
15%
Induced Apoptosis
15%
Myosin Heavy Chain 9
15%
TNF Polymorphism
15%
Mammalian Target of Rapamycin (mTOR)
15%
Wolman Disease
15%
Hematopoietic Stem Cell Transplantation
15%
Enzyme Replacement Therapy
15%
Rituximab
15%
Adjuvant Delivery
7%
Dietary Fat
7%
Fat Restriction
7%
Tubulointerstitial
6%
Spleen
6%
CD8+ Tregs
6%
Constitutive Proteasome
6%
Allograft Acceptance
6%
Human Pancreatic Ductal Adenocarcinoma
6%
